Atlas Trials

Sequential TACE and SBRT Followed by ImmunoTherapy for Downstaging HCC for Hepatectomy

Clinical trial NCT03817736 · COMPLETED

Trial details

NCT number
NCT03817736
Sponsor
The University of Hong Kong
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HCC
Start date
2019-03-01
Primary completion
2022-06-14
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.